Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Apr;80(1):232-233.
doi: 10.1007/s12020-022-03294-3. Epub 2023 Jan 6.

Glucagon-like peptide-1 receptor agonists for improving cardiorenal outcomes in type 1 diabetes mellitus?

Djordje S Popovic  1   2 , Anca Pantea Stoian  3 , Nikolaos Papanas  4
Affiliations
Comment

Glucagon-like peptide-1 receptor agonists for improving cardiorenal outcomes in type 1 diabetes mellitus?

Djordje S Popovic et al. Endocrine. 2023 Apr.
No abstract available

Keywords: Cardiovascular disease; Chronic kidney disease; Glucagon-like peptide-1 receptor agonists; Type 1 diabetes mellitus.

PubMed Disclaimer

Comment on

References

    1. D.S. Popovic, N. Papanas, Double diabetes: a growing problem requiring solutions. Exp. Clin. Endocrinol. Diabetes 130, 268–274 (2022). https://doi.org/10.1055/a-1392-0590 - DOI - PubMed
    1. M.J. Davies, V.R. Aroda, B.S. Collins et al. Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 45, 2753–2786 (2022). https://doi.org/10.2337/dci22-0034 - DOI - PubMed
    1. D.S. Popovic, E. Stokic, S.L. Popovic, GLP-1 receptor agonists and type 1 diabetes-where do we stand? Curr. Pharm. Des. 21, 5292–5298 (2015). https://doi.org/10.2174/0929867322666151006142224 - DOI - PubMed
    1. C. Mathieu, B. Zinman, J.U. Hemmingsson et al. Efficacy and safety of liraglutide added to insulin treatment in type 1 diabetes: the ADJUNCT ONE treat-to-target randomized trial. Diabetes Care 39, 1702–1710 (2016). https://doi.org/10.2337/dc16-0691 - DOI - PubMed
    1. B. Ahrén, I.B. Hirsch, T.R. Pieber et al. Efficacy and safety of liraglutide added to capped insulin treatment in subjects with type 1 diabetes: the ADJUNCT TWO randomized trial. Diabetes Care 39, 1693–1701 (2016). https://doi.org/10.2337/dc16-0690 - DOI - PubMed

MeSH terms

Substances

LinkOut - more resources